FDA approves first generic version of Nexium
On January 26, the U.S. Food and Drug Administration (FDA) approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to treat gastroesophageal…
Web Exclusives
FDA permits marking of mobile app for glucose monitoring
On January 23, the U.S. Food and Drug Administration (FDA) permitted marketing of the first set of mobile medical apps that allow people with…
Smoking may increase risks for patients receiving therapy for prostate cancer
Among patients with prostate cancer, those who smoke have increased risks of experiencing side effects from treatment and of developing future cancer recurrences, or…
FDA approves Ibrance for postmenopausal women with metastatic breast cancer
On February 3, the U.S. Food and Drug Administration (FDA) approved Ibrance (palbociclib) to treat advanced metastatic breast cancer. Read more.
FDA approves tissue adhesive for internal use
On February 4, the U.S. Food and Drug Administration (FDA) approved TissuGlu, the first tissue adhesive approved for internal use. TissuGlu is a urethane-based…
FDA to strengthen review of AEDs
On January 28, the U.S. Food and Drug Administration (FDA) announced that it will strengthen its review of automated external defibrillators (AEDs) to help…
Surgary drinks can prompt early onset of menstruation
Girls who frequently consume sugary drinks tend to start their menstrual periods earlier than girls who do not, according to a study in Human…
FDA approves new drug for psoriasis
On January 21, the U.S. Food and Drug Administration (FDA) approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis. Read more.
Only about half of teenage girls receive HPV vaccine at recommended age
A study from the University of Texas Medical Branch at Galveston found that almost half of the teenage girls they surveyed received the human…
FDA approves new anticlotting drug
On January 8, the U.S. Food and Drug Administration (FDA) approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of stroke and…
FDA approves device to treat obesity
On January 14, the U.S. Food and Drug Administration (FDA) approved the Maestro Rechargeable System for certain obese adults, the first weight loss treatment…
Lack of exercise responsible for more deaths than obesity
A study of more than 334,000 European men and women found that twice as many deaths may be attributable to lack of physical activity…
FDA approves first generic version of Nexium
On January 26, the U.S. Food and Drug Administration (FDA) approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to…
FDA permits marking of mobile app for glucose monitoring
On January 23, the U.S. Food and Drug Administration (FDA) permitted marketing of the first set of mobile medical apps that allow…
Smoking may increase risks for patients receiving therapy for prostate cancer
Among patients with prostate cancer, those who smoke have increased risks of experiencing side effects from treatment and of developing future cancer…
FDA approves Ibrance for postmenopausal women with metastatic breast cancer
On February 3, the U.S. Food and Drug Administration (FDA) approved Ibrance (palbociclib) to treat advanced metastatic breast cancer. Read more.
FDA approves tissue adhesive for internal use
On February 4, the U.S. Food and Drug Administration (FDA) approved TissuGlu, the first tissue adhesive approved for internal use. TissuGlu is…
FDA to strengthen review of AEDs
On January 28, the U.S. Food and Drug Administration (FDA) announced that it will strengthen its review of automated external defibrillators (AEDs)…
Surgary drinks can prompt early onset of menstruation
Girls who frequently consume sugary drinks tend to start their menstrual periods earlier than girls who do not, according to a study…
FDA approves new drug for psoriasis
On January 21, the U.S. Food and Drug Administration (FDA) approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis. Read more.
Only about half of teenage girls receive HPV vaccine at recommended age
A study from the University of Texas Medical Branch at Galveston found that almost half of the teenage girls they surveyed received…
FDA approves new anticlotting drug
On January 8, the U.S. Food and Drug Administration (FDA) approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of…
FDA approves device to treat obesity
On January 14, the U.S. Food and Drug Administration (FDA) approved the Maestro Rechargeable System for certain obese adults, the first weight…
Lack of exercise responsible for more deaths than obesity
A study of more than 334,000 European men and women found that twice as many deaths may be attributable to lack of…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.